<DOC>
	<DOCNO>NCT01325584</DOCNO>
	<brief_summary>The purpose study make Omegaven速 available cancer patient liver disease determine Omegaven速 improve prevent liver disease . The study also look effect Omegaven速 immune function .</brief_summary>
	<brief_title>Compassionate Use Omegaven速 Treatment Parenteral Nutrition Induced Hepatic Injury</brief_title>
	<detailed_description>This compassionate use study include patient advanced cancer require PN long-term nutrition support develop PN-induced hepatic injury exist hepatic dysfunction . Therapy Omegaven provide initial dose 0.1 g/kg body weight ( 1ml/kg ) increase 0.2 g/kg body weight ( 2ml/kg ) day 2 3 treatment . For patient &gt; 120 % ideal body weight , adjust body weight use . The infusion rate exceed 0.5mL Omegaven/kg body weight/hr ( correspond 0.05g fish oil/kg/hr ) . Omegaven co-administered via y-site infusion , container change every 12 hour . The patient may receive lipid meet Essential Fatty Acid ( EFA ) and/or additional calorie need . Patients receive initial infusion PN contain Omegaven Midwestern Regional Medical Center ( MRMC ) infusion center observe adverse reaction . If adverse reaction observe , IV steroid &amp; benadryl administer &amp; Omegaven discontinue . Patients continue receive infusion CTCA first 2 3 day dose . After tolerance establish , patient receive treatment home Coram . All study patient Screening Visit ; Day 1 , Day 2 Day 3 visit ; weekly visit one month ( see Table 2 ) .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>1 . Male Female ; age 18 80 year old 2 . Receiving treatment Cancer Treatment Centers America 3 . Receiving PN ( either infusion center home ) 4 . Have exist hepatic dysfunction define Elevation &gt; 3x normal level one following : Alkaline Phosphatase ( ALP ) , Aspartate Aminotransferase ( AST ) , Alanine Aminotransferase ALT ) and/or Bilirubin &gt; 2 mg/dl absence biliary obstruction 5 . Able provide inform write consent 1 . Hypertriglyceridemia ( triglyceride [ TG ] &gt; 400 ) 2 . Allergy fish egg protein 3 . Currently therapeutic dos Coumadin , heparin , low molecular eight heparin 4 . Hemodynamically unstable 5 . Bilirubin &gt; 5 mg/dL 6 . Documented liver metastases 7 . Unstable diabetes know diabetic ketoacidosis within 7 day screen 8 . Recent cardiac infarction ( within 6 month ) take plavix 9 . Severe hemorrhagic disorder 10 . Current anticoagulation therapy deep venous thromboembolism pulmonary embolism 11 . Active sepsis 12 . Undefined coma status 13 . In patient abnormal kidney function , renal insufficiency calculate creatinine clearance &lt; 30 mL/min 14 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>